World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
93
Citations
43151
World Ranking
950
National Ranking
522

Medicine

D-Index
93
Citations
43152
World Ranking
10698
National Ranking
5500

Ronald E. Gress publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Ronald E. Gress sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 439 publications — 85th percentile

85% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Ronald E. Gress D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Ronald E. Gress sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 93 D-Index — 81st percentile

81% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Ronald E. Gress is affiliated with the National Institutes of Health in the United States. Their research spans primarily the fields of Medicine and Immunology and Microbiology, with a focused interest in subfields such as Immunology, Hematology, Oncology, Genetics, and Epidemiology.

The scientist's work concentrates on several main topics related to hematologic and immunologic research. These include:

  • Hematopoietic Stem Cell Transplantation
  • Immune Cell Function and Interaction
  • T-cell and B-cell Immunology
  • CAR-T cell therapy research
  • Cytomegalovirus and herpesvirus research
  • Polyomavirus and related diseases
  • Chronic Lymphocytic Leukemia Research

Ronald E. Gress has contributed extensively to scientific literature, publishing in journals and venues such as:

  • Transplantation and Cellular Therapy
  • Blood
  • Biology of Blood and Marrow Transplantation
  • Nature Medicine
  • Frontiers in Immunology

Among the recent papers authored or co-authored by Ronald E. Gress are:

  • "Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma," 2020, Nature Medicine
  • "Glycolytic metabolism of pathogenic T cells enables early detection of GVHD by 13C-MRI," 2021, Blood
  • "Phase I/II Study of Reduced Dosing of Post-Transplantation Cyclophosphamide (PTCy) after HLA-Haploidentical Bone Marrow Transplantation", 2021, Blood
  • "Immune Response Following Quadrivalent Human Papillomavirus Vaccination in Women After Hematopoietic Allogeneic Stem Cell Transplant," 2020, JAMA Oncology
  • "In vivo availability of the cytokine IL-7 constrains the survival and homeostasis of peripheral iNKT cells," 2022, Cell Reports

Frequent collaborators in their research include:

  • Steven Z. Pavletic
  • Seth M. Steinberg
  • Jennifer A. Kanakry
  • Dimana Dimitrova
  • Don Farthing

Best Publications

  • Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases.

    Shimon Sakaguchi;Noriko Sakaguchi;Masanao Asano;Misako Itoh

  • Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective.

    Marcie Tomblyn;Tom Chiller;Hermann Einsele;Ronald Gress

  • Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective

    M. Tomblyn;T. Chiller;H. Einsele;R. Gress

  • Age, thymopoiesis, and CD4+ t-lymphocyte regeneration after intensive chemotherapy

    Crystal L. Mackall;Thomas A. Fleisher;Margaret R. Brown;Mary P. Andrich

  • T cells expressing an anti-B-cell maturation antigen chimeric antigen receptor cause remissions of multiple myeloma

    Syed Abbas Ali;Victoria Shi;Irina Maric;Michael Wang

  • T Cells Genetically Modified to Express an Anti–B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma

    Jennifer N. Brudno;Irina Maric;Steven D. Hartman;Jeremy J. Rose

  • Allogeneic T Cells That Express an Anti-CD19 Chimeric Antigen Receptor Induce Remissions of B-Cell Malignancies That Progress After Allogeneic Hematopoietic Stem-Cell Transplantation Without Causing Graft-Versus-Host Disease

    Jennifer N. Brudno;Robert P.T. Somerville;Victoria Shi;Jeremy J. Rose

  • Tumor-Evoked Regulatory B Cells Promote Breast Cancer Metastasis by Converting Resting CD4+ T Cells to T-Regulatory Cells

    Purevdorj B. Olkhanud;Bazarragchaa Damdinsuren;Monica Bodogai;Ronald E. Gress

  • B-cell Maturation Antigen Is a Promising Target for Adoptive T-cell Therapy of Multiple Myeloma

    Robert O. Carpenter;Moses O. Evbuomwan;Stefania Pittaluga;Jeremy J. Rose

  • Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation.

    James N. Kochenderfer;Mark E. Dudley;Robert O. Carpenter;Sadik H. Kassim

  • Harnessing the biology of IL-7 for therapeutic application

    Crystal L. Mackall;Terry J. Fry;Ronald E. Gress

  • Two antigen-independent adhesion pathways used by human cytotoxic T-cell clones

    Stephen Shaw;Gale E. Ginther Luce;Ralph Quinones;Ronald E. Gress

  • Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients

    Paolo A. Muraro;Daniel C. Douek;Amy Packer;Katherine Chung

  • Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets

    Claude Sportès;Frances T. Hakim;Sarfraz A. Memon;Hua Zhang

  • IL-7 administration to humans leads to expansion of CD8+ and CD4+ cells but a relative decrease of CD4+ T-regulatory cells.

    Steven A. Rosenberg;Claude Sportès;Mojgan Ahmadzadeh;Terry J. Fry

  • Thymic-independent T cell regeneration occurs via antigen-driven expansion of peripheral T cells resulting in a repertoire that is limited in diversity and prone to skewing.

    Crystal L. Mackall;Catherine V. Bare;Larry A. Granger;Susan O. Sharrow

  • Distinctions Between CD8+ and CD4+ T-Cell Regenerative Pathways Result in Prolonged T-Cell Subset Imbalance After Intensive Chemotherapy

    Crystal L. Mackall;Thomas A. Fleisher;Thomas A. Fleisher;Margaret R. Brown;Margaret R. Brown;Mary P. Andrich;Mary P. Andrich

  • T cell immune reconstitution following lymphodepletion.

    Kirsten M. Williams;Frances T. Hakim;Ronald E. Gress

  • Lymphocyte depletion during treatment with intensive chemotherapy for cancer.

    Crystal L. Mackall;Thomas A. Fleisher;Margaret R. Brown;Ian T. Magrath

  • L-Selectinhi but not the L-selectinlo CD4+25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection

    Patricia A. Taylor;Angela Panoskaltsis-Mortari;Jessica M. Swedin;Philip J. Lucas

Frequent Co-Authors

Steven Z. Pavletic
Steven Z. Pavletic National Institutes of Health
Seth M. Steinberg
Seth M. Steinberg National Institutes of Health
Crystal L. Mackall
Crystal L. Mackall Stanford University
David F. Stroncek
David F. Stroncek National Institutes of Health
James N. Kochenderfer
James N. Kochenderfer National Institutes of Health
Terry J. Fry
Terry J. Fry University of Colorado Denver
Carl H. June
Carl H. June University of Pennsylvania
Bruce L. Levine
Bruce L. Levine University of Pennsylvania
Michael Eckhaus
Michael Eckhaus National Institutes of Health
Susan F. Leitman
Susan F. Leitman National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in advancing their careers in Immunology, exploring related nursing degrees can open new professional opportunities. Transitioning from a Family Nurse Practitioner (FNP) role to a more specialized acute care position often requires additional education, and programs like the fnp to acute care np bridge program provide a focused pathway to achieve this goal.

Many students prefer flexibility, making accelerated programs a popular choice. The accelerated np programs online enable learners to fast-track their nurse practitioner credentials while balancing other commitments.

For those without a nursing background, starting with foundational education is essential. Online options like the online rn programs for non nurses offer a convenient route into the nursing field, paving the way for future specialization in Immunology or related healthcare areas.

Additionally, some students seek programs that are more accessible and have fewer barriers to entry. Exploring the easiest absn programs to get into can help candidates quickly begin their Bachelor of Science in Nursing and eventually focus on Immunology-related careers.

Best Scientists Citing Ronald E. Gress

Trending Scientists

Recently Published Articles